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In this study, we compared acute and chronic bone marker and hormone responses to
6 weeks of low intensity (20% 1RM) blood flow restriction (BFR20) resistance training to
high intensity (70% 1RM) traditional resistance training (TR70) and moderate intensity
(45% 1RM) traditional resistance training (TR45) in young men (18–35 years). Participants
were randomized to one of the training groups or to a control group (CON). The following
training programs were performed 3 days per week for 6 weeks for knee extension and
knee flexion exercises: BFR20, 20%1RM, 4 sets (30, 15, 15, 15 reps) wearing blood flow
restriction cuffs around the proximal thighs; TR70, 70% 1RM 3 sets 10 reps; and TR45,
45% 1RM 3 sets 15 reps. Muscle strength and thigh cross-sectional area were assessed
at baseline, between week 3 and 6 of training. Acute bone marker (Bone ALP, CTX-I) and
hormone (testosterone, IGF-1, IGFBP-3, cortisol) responses were assessed at weeks 1
and 6, with blood collection done in the morning after an overnight fast. The main findings
were that the acute bone formation marker (Bone ALP) showed significant changes for
TR70 and BFR20 but there was no difference between weeks 1 and 6. TR70 had acute
increases in testosterone, IGF-1, and IGFBP-3 (weeks 1 and 6). BFR20 had significant
acute increases in testosterone (weeks 1 and 6) and in IGF-1 at week 6, while TR45 had
significant acute increases in testosterone (week 1), IGF-1 (week 6), and IGFBP-3 (week
6). Strength and muscle size gains were similar for the training groups. In conclusion, low
intensity BFR resistance training was effective for stimulating acute bone formation marker
and hormone responses, although TR70 showed the more consistent hormone responses
than the other training groups.
Keywords: bone metabolism, hormones, muscle hypertrophy, strength, resistance training
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INTRODUCTION

and chronic resistance training protocols (Pasqualini et al.,
2019); however, the effects of low intensity BFR resistance
exercise on bone marker responses has not been extensively
examined. We previously reported that the bone resorption
marker, N-terminal cross-linking telopeptide of type I collagen
(NTX-I), decreased 30 min after a single bout of low intensity
BFR resistance exercise in young men, thus reflecting a decrease
in bone resorption rate in response to the exercise (Bemben
et al., 2007). The results are mixed for bone responses to
chronic BFR training programs. Kim et al. (2012) found no
changes in bone markers in response to 3 weeks of BFR training
in young men, in contrast to a significant increase in the
bone formation marker, bone-specific alkaline phosphatase
(Bone ALP) in the high intensity traditional resistance exercise
group indicating an increase in bone formation only for the
high intensity exercise stimulus. However, Bone ALP significantly
increased after 6 weeks of BFR training in older men, and the
increase was similar in magnitude to the high intensity resistance
training group (Karabulut et al., 2011). Linero and Choi (2021)
conducted a 12-week study comparing bone marker responses
to low intensity (30% 1RM) BFR resistance exercise and
moderate-high intensity (60–80% 1RM) traditional resistance
exercise in postmenopausal women with osteoporosis or low
bone mass. The bone resorption marker, C-terminal crosslinking telopeptide of type I collagen (CTX-I), significantly
increased only in the moderate-high intensity training group.
All groups, including the control group, had significant increases
in the bone formation marker, procollagen type 1 N-terminal
propeptide (P1NP), suggesting this bone formation marker
response was a seasonal effect, rather than a training effect.
At present, the underlying mechanisms responsible for these
adaptations are unclear as low intensity BFR resistance exercise
does not apply high magnitude external loads on bone. It
could affect bone metabolism by increased intramedullary
pressures and interstitial fluids through increased vascular
restriction (Loenneke et al., 2012). Also, BFR results in a
hypoxic condition that could activate hypoxia induced
transcription factor (HIF) leading to increased expression of
vascular endothelial growth factor (VEGF) and the formation
of new blood vessels in the bone tissue (Araldi and Schipani,
2010). Bone formation (osteoblasts) and bone resorption
(osteoclasts) cells are functionally linked to blood vessels, which
transport osteoblast and osteoclast precursors to the local
remodeling sites; this cross-talk between bone and vascular
cells is recognized as critical for bone remodeling (LafageProust and Roche, 2019).
Hormones play an important role in modulating intracellular
signaling pathways, including signaling pathways that regulate
muscle cell growth in response to resistance exercise (Kraemer
et al., 2020; Gharahdaghi et al., 2021). Anabolic hormones,
such as testosterone, growth hormone, and IGF-1, promote
muscle hypertrophy via genomic (e.g., alter gene expression)
and non-genomic (e.g., increase calcium release, mTOR pathway
activation) signaling (Kraemer et al., 2020; Gharahdaghi et al.,
2021). These hormones also regulate bone metabolism by
promoting bone formation and/or inhibiting bone resorption
(Hamdy and Appelman-Dijkstra, 2019; Shigehara et al., 2021).

Low intensity resistance exercise combined with blood flow
restriction (BFR) has been shown to improve muscle strength
and mass (Abe et al., 2005; Laurentino et al., 2012; Bjørnsen
et al., 2019); however, a meta-analysis by Lixandrão et al.
(2018) suggests that BFR training stimulates similar gains in
muscle hypertrophy but smaller increases in strength compared
to traditional high intensity resistance training intensity (≥65%
1 repetition maximum, 1RM). This type of training program
may be beneficial for individuals who have difficulty performing
high intensity resistance exercise, such as those with chronic
diseases such as multiple sclerosis, osteoporosis, and osteoarthritis
(Freitas et al., 2021).
Possible mechanisms for the adaptations that occur with
BFR exercise include enhanced metabolic stress resulting from
the accumulation of metabolic by-products in the occluded
limbs affecting fast-twitch motor unit recruitment and the
secretion of hormones and factors that promote protein synthesis
and angiogenesis (Takarada et al., 2000; Suga et al., 2012;
Karabulut et al., 2014). Acute bouts of BFR resistance exercise
stimulate increases in blood lactate and anabolic hormones
(e.g., growth hormone, testosterone, insulin-like growth factor-1,
IGF-1) with minimal changes in muscle damage markers
(Takarada et al., 2000; Abe et al., 2005; Takano et al., 2005;
Madarame et al., 2010; Manini et al., 2012; Yinghao et al.,
2021). Another mechanism is the activation of localized
chemoreceptors and exercise-induced muscle swelling, often
observed following BFR exercise, that may play a role in shifting
the protein balance toward anabolism. Wilson et al. (2013)
reported that muscle activation increased by ~20 mV and
swelling increased 0.5 cm, while muscle damage indices remained
unchanged during acute bouts of practical BFR. It is welldocumented that low intensity BFR resistance exercise increases
muscle protein synthesis by altering signaling pathways, including
the mammalian target of rapamycin complex 1 (mTORC1)
and the inhibition of atrogenes like Muscle RING Finger1
(MuRF1) and atrogin-1 and the inhibition of the myostatin
pathway (Fujita et al., 2007; Fry et al., 2010; Laurentino
et al., 2012).
It is well established that mechanical loading induces positive
effects on bone metabolism. For example, high intensity
traditional resistance exercise has been shown to result in small
(~1–3%) but significant increases in bone mineral density
(BMD) at clinically relevant skeletal sites assessed by dual
energy x-ray absorptiometry (DXA; see meta-analyses by Zhao
et al., 2015; Shojaa et al., 2020). In addition to BMD, bone
metabolism is frequently assessed by serum bone turnover
markers; these biomarkers reflect the bone formation and bone
resorption phases of the bone remodeling cycle (Szulc et al.,
2019), and have several advantages as they respond more rapidly
to treatments than DXA measurements and they may show
greater responses than BMD (Bauer et al., 2012), making them
very useful for evaluating bone responses to exercise interventions
that are shorter in duration (e.g., <6 months) than the bone
remodeling cycle. Previous studies have documented significant
bone marker responses to both acute (Bemben et al., 2015)
Frontiers in Physiology | www.frontiersin.org
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Cortisol is a glucocorticoid hormone released in response to
stress, such as high intensity/volume resistance exercise that
exerts catabolic effects on muscle and bone tissue. Cortisol
increases energy substrate availability through protein breakdown
and counteracts muscle inflammation (Kraemer et al., 2020).
Chronically elevated cortisol is associated with bone loss and
increased bone fragility (Hamdy and Appelman-Dijkstra, 2019).
Acute bouts of BFR resistance exercise have been shown to
stimulate significant increases in testosterone (Madarame et al.,
2010; Yinghao et al., 2021) and IGF-1 (Takano et al., 2005;
Madarame et al., 2010; Yinghao et al., 2021) serum concentrations;
however, the hormone adaptations to chronic BFR resistance
training are not clear. Abe et al. (2005) reported a significant
increase in resting serum IGF-1 concentrations after 2 weeks
of BFR resistance training in young men, whereas Karabulut
et al. (2013) found no significant changes in resting IGF-1,
testosterone, or insulin-like growth factor binding protein-3
(IGFBP-3) serum concentrations in response to 6 weeks of
either low intensity BFR or high intensity resistance training
in older men. Also, the effects of BFR training programs on
acute hormone responses to single bouts of resistance exercise
have not been established.
While there is a growing body of literature related to BFR,
there is a paucity of training studies that directly compare
bone marker and hormone responses to low intensity BFR
resistance exercise and traditional resistance exercise protocols.
The purpose of this study was to compare acute and chronic
effects of 6 weeks of low intensity (20% 1RM) blood flow
restriction resistance training to high intensity (70% 1RM)
and moderate intensity (45% 1RM) traditional resistance training
programs on bone marker and endocrine responses in
18–35 year-old males. We hypothesized that acute bone marker
and endocrine responses would be similar for the low intensity
BFR and the high intensity resistance exercise groups, and
that the responses for these two groups would be greater than
the moderate intensity resistance exercise group and the control
group. We expected that 6 weeks of low intensity BFR resistance
training would elicit positive bone marker adaptations indicating
increased bone formation (increased Bone ALP) and decreased
bone resorption (decreased CTX-I) rates, however, these chronic
responses would be greater in the high intensity resistance
exercise group compared to the other training groups.
We hypothesized that low intensity BFR training and high
intensity resistance training would elicit similar hormone
adaptations with an increase in anabolic hormones and a
decrease in cortisol.

resistance training program for the previous 4 months prior
to the beginning of the study. Information regarding past and
present health status was obtained through a health status
questionnaire and a pre-participation questionnaire (Par-Q).
Males with cardiovascular, pulmonary or metabolic disease,
orthopedic problems, or smokers were excluded from the study.
The university institutional review board approved this study,
which was written in accordance with standards set by the
Declaration of Helsinki.

Research Design

This study utilized a randomized control repeated measures
design where participants were randomly assigned to one of
four groups: high intensity traditional resistance training (70%
1RM: TR70, n = 12), moderate intensity traditional resistance
training (45% 1RM: TR45, n = 9), low intensity resistance training
with blood flow restriction (20% 1RM + Blood Flow Restriction:
BFR20, n = 12) groups, or to a control group (CON, n = 8).
Exercise groups trained 3 days Per week for 6 weeks while the
control group maintained their normal daily activities and only
participated in the pre, mid (week 3), and post training
testing sessions.
During the pre, mid, and post testing sessions, participants
were assessed for 1RM maximal strength for each of the six
exercises used during training (lat pull down, biceps curl, triceps
extension, shoulder press, knee flexion, and knee extension;
Figure 1). Blood samples were obtained at the Pre and post
exercise sessions at baseline and week six of training and were
analyzed for hormones (total testosterone, IGF-1, IGFBP-3,
cortisol) and bone turnover markers (Bone ALP, CTX-I). Body
composition (total body scans) was assessed pre- and posttraining and thigh muscle cross-sectional areas (femur scans)
were assessed pre-, mid- (week 3), and post-training.

Training Protocols

Following baseline testing, participants were randomly assigned
to the TR70, TR45, BFR20 training groups, or to a control
group. Participants in the TR70 (n = 12), TR45 (n = 9), and
BFR20 (n = 12) groups trained 3 days a week for about 1 h per
session for 6 weeks. All sessions were monitored by trained
lab staff. Participants began each training session with a 5 min
standardized warm-up on cycle ergometer and 5 min stretching.
Participants in the TR70 group performed four upper body
exercises at 50% 1RM, 3 sets, 10 repetitions (lat pull down,
shoulder press, biceps curl, and triceps extension) and two
lower body exercises (knee flexion and knee extension) for 3
sets of 10 repetitions at 70% 1RM. Participants in the TR45
performed the same four upper body exercises at 50% 1RM,
3 sets, 10 repetitions and the knee flexion and knee extension
exercises for 3 sets of 15 repetitions at 45% 1RM. Participants
in the BFR20 group performed the same upper body exercises
at the same intensity (50% 1RM), but performed the exercises
for the lower body with specially designed restrictive cuffs
(50 mm width, KAATSU Master, Sato Sports Plaza, Tokyo,
Japan) placed at the upper most portion (1–2 cm distal to the
inguinal folds) of both thighs. Participants completed 4 sets,

MATERIALS AND METHODS
Participants

Forty-three recreationally active healthy men aged from 18 to
35 years met the study inclusion criteria and gave their written
informed consent to participate in the study. Two participants
(1 from moderate intensity group, 1 from control group)
dropped from the study prior to the pre-testing due to time
constraints. Participants must not have been engaged in a
Frontiers in Physiology | www.frontiersin.org
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FIGURE 1 | Study protocol.

with the 30 repetitions in the first set and 15 reps for the
remaining 3 sets at 20% 1RM. One minute rest separated each
set of exercises for each training group. The initial restrictive
cuff pressure was between 40 and 60 mmHg, and then the
pressure was increased incrementally by 20 mmHg from 120
to 180 mmHg, inflated for 30 s and deflated for 10 s, until the
training pressure of 160 mmHg was reached. One minute of
rest separate each of the two BFR leg exercises and once both
exercises were completed the cuffs were deflated and removed.
Training loads were adjusted for strength gains after week 3
to maintain the required relative intensities. For the BFR20
group, cuff pressure was progressively increased every 2 weeks
of training from 160 mmHg for weeks 1–2, 180 mmHg for
weeks 3–4, and 200 mmHg for weeks 5–6. The control group
(n = 8) participated in the pre, mid (week 3), and post testing
sessions and were asked to maintain their normal daily activities
over the course of the 6 week intervention.

estimated a load of about 50% of 1RM and subjects completed
five repetitions. Then three repetitions were completed at about
80% of 1RM. The maximal load that could be successfully
lifted was then determined within five attempts. One minute
rest periods separated each attempt and 5 min of rest separated
different muscle groups. Testing order was as follows: lat pull
down, shoulder press, knee extension, bicep curl, triceps
extension, and knee flexion.

Body Composition and Thigh Muscle
Cross Sectional Area

Total and regional body composition was assessed Pre and
post training by dual energy x-ray absorptiometry (DXA) (GE
Lunar Prodigy, enCORE software version 6.70.021; GE Healthcare,
Madison WI). First, height was measured with a wall stadiometer
(cm) and body mass was measured using a standard electronic
scale (kg). Participants then were positioned on the DXA table
for the total body scan. Scan speeds were determined by the
truncal thickness (thick >25 cm; standard 13–15 cm, and thin
<13 cm). Percent body fat (%BF), fat mass (FM), fat free mass
(FFM) and total and regional bone free lean body mass (BFLBM)
variables were obtained from the total body scan analysis. The
DXA was calibrated prior to each testing session by a single
trained laboratory technician. In this laboratory, root-meansquare coefficients of variation (RMS CV%) for %BF, FM,
BFLBM, and FFM are 1.9%, 1.6%, 1.3%, and 1.2%, respectively.
Mid-thigh muscle cross-sectional area (MCSA) was obtained
by pQCT (XCT 3000, Stratec Medizintechnik GmbH, Pforzheim,
Germany) by a trained technician at baseline, week 3, and
post training. Scans were obtained on the non-dominant leg

Muscular Strength Testing

1RM tests were performed at baseline to determine the
appropriate training workloads and maximum strength for each
exercise (lat pull down, biceps curl, shoulder press, triceps
extension, knee flexion, and knee extension). 1RM’s were
reassessed at the midpoint of training (week 3), and after
completion of the training protocol (week 6). Resistance exercises
were performed using Cybex machines (Cybex International
Inc., Medway, MA, United States). All testing was completed
by trained laboratory staff following standardized protocols
and after participants were familiarized with each lift and had
completed a warm-up on a stationary bicycle. Each test first
Frontiers in Physiology | www.frontiersin.org
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at 50% of femur length. Participants were seated in the scanning
chair with the leg in the support straps, positioned in the
center of the gantry, and participant was asked to remain still
and to breathe normally during the scan acquisition. Scans
were acquired with a voxel size of 0.4 mm, a slice thickness
of 2.2 mm, and a scan speed of 20 mm/s. Obtaining MCSA
values requires two “CalcBd” analyses to separate muscle, fat,
and bone. Scan analyses for MCSA used a threshold driven
contour detection (Mode 1) and Peel (Mode 2). The thresholds
used in analysis 1 were −100 and 40, and the thresholds used
in analysis 2 were 710 and 40. MCSA is derived by subtracting
the “subcortical area” of analysis 2 from “subcortical area” of
analysis 1. The same technician performed all scans. In our
laboratory, the 50% femur site precision value (RMS CV%) is
1.6% for MCSA.

from 4.1% to 8.4% and inter assay CV% ranged from 1.4%
to 5.1% for CTX-I.
Serum hormone concentrations (IGF-1, IGFBP-3, total
testosterone, and cortisol) were assayed in duplicate using the
following kits: IGF-I ELISA (Immunodiagnostic Systems Inc.,
Fountain Hills AZ); IGFBP-3 ELISA (ALPCO Diagnostics,
Salem NH); Testosterone (Serum) EIA (ALPCO Diagnostics,
Salem NH); and Cortisol ELISA (ALPCO Diagnostics, Salem
NH). The intra assay CV% ranged from 4.2% to 9.2% and
the inter assay CV% ranged from 6.4% to 15.9%.

Statistical Analyses

Statistical analyses were performed using IBM SPSS for Windows
(v. 26). All data are represented as Mean ± SD unless otherwise
stated. Sample sizes were adequate for 80% power based an
effect size of 1.68 for acute bone marker responses (Bemben
et al., 2007) and an expected moderate effect size of 0.8 for
strength variables (Rhea, 2004). Normality of dependent variables
was examined by the Shapiro-Wilks test, skewness and kurtosis,
and Q‑Q plots. Group differences in baseline dependent variables
were analyzed using a one-way analysis of variance (ANOVA).
Three-way mixed factorial repeated measures ANOVA
[Group × Training (Week 1, Week 6) × Time (Pre, IP, 60P)] was
used to determine acute and chronic bone marker and hormone
serum concentration responses. If there were significant
interaction effects, then the model was decomposed using
two-way repeated measures ANOVA (training × time) with
Bonferroni post hoc tests within each group. Percent changes
in blood variables were analyzed by two-way repeated measures
ANOVA Group × Training (Week 1, Week 6) with Bonferroni
post hoc tests. Pearson correlation coefficients (r) were computed
to determine relationships between absolutes changes in hormone
variables and muscle strength/CSA variables. Effect sizes for
the ANOVA results were calculated as partial eta squared (ηp2),
which were classified as small (0.0099), medium (0.0588), or
large (0.1379) (Richardson, 2011). Statistical significance was
set at a probability of p ≤ 0.05.

Blood Samples and Biochemical Assays

Venous blood collection occurred in the morning with the
subjects in 8 h fasted state to minimize the diurnal variation
effects on bone markers and hormones. One Pre (Pre) and
one post exercise (IP) blood sample was obtained by a nurse
on the first (WK 1) and last (WK 6) days of training. Bone
markers also were measured 60 min post exercise (60P). The
control group attended the blood draw sessions but remained
in a rested seated position for the same time intervals. Blood
samples were allowed to clot then centrifuged to obtain the
serum, which as aliquoted into 0.5 ml microtubes, frozen at
−80°C, and thawed only one time prior to each assay to reduce
protein degradation.
Hematocrit (%) was measured at pre and IP in duplicate
using capillary tubes centrifuged with a CritSpin Microhematocrit
Centrifuge (StatSpin, Norwood, MA, United States), and read
on a CritSpin Digital Reader (StatSpin, Norwood, MA,
United States). Lactate was measured at Pre and IP using a
Lactate Plus Portable Lactate Analyzer (Nova Biomedical,
Waltham MA, United States). Percent change in plasma volume
from pre to IP (%∆PV) was determined with the following
equation: %∆PV = {100/(100 − Hct Pre) × 100[(Hct Pre − Hct
Post)/Hct Post]}; Van Beaumont, 1972). Since plasma volume
shifts occur during acute bouts of exercise, it is important to
correct blood-borne substances (e.g., hormones, bone markers)
for the effects of hemoconcentration to determine whether
the response is a true metabolic response to the exercise protocol
(Brahm et al., 1997). Bone marker and hormone serum
concentrations were adjusted for plasma volume changes using
the following formula: Corrected concentration = Uncorrected
concentration × [(100 + ΔPV%)/100].
Serum concentrations of the bone formation marker,
Bone-specific Alkaline Phosphatase (Bone ALP), was assessed
in duplicate using a Metra BAP Enzyme ImmunoAssay (EIA)
kit (Quidel Corporation, Mountain View, CA, United States).
Inter assay coefficients of variation (CV%) for Bone ALP
assays ranged from 5.2% to 6.8%, and intra assay CV%
ranged from 4.5% to 13.1%. The bone resorption marker,
C-terminal Telopeptide of Type I Collagen (CTX-I), was
measured in duplicate using a commercial ELISA kit
(Immunodiagnostics Systems, Inc.). Intra assay CV% ranged
Frontiers in Physiology | www.frontiersin.org

RESULTS
Physical Characteristics and Body
Composition

At baseline, the CON group was significantly older (p = 0.002)
than the other three groups (Table 1). There was a significant
group effect for height (p = 0.039), but post hoc analyses did
not detect any group differences. There were no group differences
for any of the body composition variables (total or regional;
Supplementary Table 1) or for mid-thigh muscle CSA at
baseline (Table 2).
There were significant training effects for both BFLBM
(p < 0.0002, np2 = 0.335) and FFM (p < 0.0002, np2 = 0.334), which
increased pre- to post-training; however, there were no significant
group or group × training interaction effects. There were no
significant group differences in percent changes pre- to
post-training in body composition variables (Figure 2). Mid-thigh
muscle CSA area significantly increased from pre- to
5
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mid- (p = 0.028), pre- to post- (p < 0.001), and mid- to
post-training (p = 0.026), but there were no significant differences
between groups for the gains in muscle CSA (Table 2). Although
there were no significant group differences in muscle CSA
percent changes, percent increases pre- to post-training for
the training groups exceeded the pQCT precision error (1.9%),
while the CON group percent changes were within the precision
error. There were no significant correlations between absolute
changes in hormone responses and body composition and
muscle CSA absolute change variables.

group × time interaction effects for blood lactate, which
significantly increased pre to IP for weeks 1 and 6 (all p < 0.0002)
for the training groups but not for CON. Blood lactate at IP
(both weeks 1 and 6) was significantly higher (all p < 0.0001)
for the training groups vs. CON. Also, TR70 had higher blood
lactate concentrations at IP than BFR20 (week 1 p = 0.035,
week 6 p < 0.0001).

Bone Turnover Markers

Bone marker responses to the acute resistance exercise protocols
at weeks 1 and 6 of training are shown in Table 4. Effect
sizes for three way repeated measures ANOVA bone marker
analyses are shown in Supplementary Table 2. Large effect
sizes (np2 ≥ 0.1379) were observed for the significant effects for
Bone ALP and CTX-I. Resting Bone ALP and CTX-I
concentrations were not significantly different between groups
nor different between weeks 1 and 6 of training. There were
significant time (p < 0.0001, np2 = 0.357) and group × time
interaction effects (p < 0.0002, np2 = 0.295) for Bone ALP. TR70
had significant Bone ALP increases from Pre to IP followed
by decreases from IP to 60P (all p < 0.007), BFR20 had a
significant decrease from IP to 60P (p = 0.001), but TR45 or
CON did not exhibit any time point differences. Similar patterns
of responses were observed for percent changes in Bone ALP
with TR70 and BFR20 showing significant time effects (both
p ≤ 0.001) as percent increases at IP were followed by decreases
at 60P (Figure 3A). CTX-I had a significant time effect
(p < 0.0001, np2 = 0.558) showing a continual decrease from Pre
to 60P (all p < 0.004) for all groups. CTX-I percent changes
had significant time (p < 0.0001) and group × training × time
(p = 0.047) interaction effects as TR70, BFR20, and CON groups
had significantly greater percent decreases at 60P compared
to IP (all p < 0.004) that was not observed for TR45 (Figure 3B).
TR70 also had a significant training × time interaction (p = 0.027)
showing a greater percent decrease in CTX-I at 60P for week
1 compared to week 6. Bone marker concentrations corrected
for plasma volume changes are shown in Supplementary Table 3.
There were no significant effects for Bone ALP after correcting

Blood Lactate and Plasma Volume
Changes

Blood lactate and plasma volume changes are presented in
Table 3. There were missing hematocrit values for four
participants (TR70 n = 1, BFR20 n = 1, CON n = 2) in week 1
blood testing, thus, n = 37 for plasma volume changes for that
week. Plasma volume decreased for all training groups, and
the percent changes pre to IP at week six were significantly
different for training groups compared to CON (all p ≤ 0.03).
There were significant group (p < 0.0001), time (p < 0.0001) and

TABLE 1 | Baseline participant characteristics.
Group
Variable

Age (years)a
Height (cm)a
Weight (kg)
% Body fat
FM (kg)
BFLBM (kg)
FFM (kg)

TR70 (n = 12)

TR45 (n = 9)

BFR20 (n = 12)

CON (n = 8)

20.9 ± 2.9**
179.9 ± 7.5
82.8 ± 24.4
19.7 ± 10.4
18.32 ± 15.98
60.57 ± 8.36
64.01 ± 8.93

20.6 ± 1.7**
176.7 ± 5.7
71.0 ± 7.8
16.3 ± 5.8
11.70 ± 5.32
55.99 ± 5.70
59.24 ± 6.06

21.3 ± 2.5**
179.7 ± 4.4
83.5 ± 17.8
23.5 ± 8.1
20.58 ± 10.67
59.23 ± 8.27
62.64 ± 8.69

25.6 ± 4
172.9 ± 3.6
84.8 ± 17.2
24.4 ± 7.9
21.47 ± 9.82
59.26 ± 7.84
62.75 ± 8.33

Values are mean ± SD. TR70, high intensity 70% 1RM; TR45, moderate intensity 45%
1RM; BFR20, blood flow restriction 20% 1RM; CON, control; FM, fat mass; BFLBM,
Bone-free lean body mass; and FFM, fat-free mass. aSignificant group effect.
**p ≤ 0.01 vs. CON.

TABLE 2 | Mid-thigh muscle cross-sectional areas as measured by pQCT at baseline (pre), week 3 (mid), and post-training (post).
Group
Variable
TR70 (n = 12)

TR45 (n = 9)

BFR20 (n = 12)

CON (n = 8)

MCSA (mm2)b
 Pre

17167.4 ± 2702.8
17379.3 ± 2670.2
17526.6 ± 2714.9

15505.4 ± 1746.5
15771.3 ± 1736.5
16129.5 ± 1818.6

16162.0 ± 2564.4
16372.7 ± 2443.9
16603.9 ± 2703.8

17250.8 ± 2673.7

 Mid*
 Post**†

211.9 ± 404.5
359.2 ± 341.5

265.8 ± 458.0
624.1 ± 492.7

210.7 ± 586.5
441.8 ± 318.6

145.2 ± 412.8
84.1 ± 513.7

1.32 ± 2.55
2.15 ± 1.99

1.78 ± 2.92
4.09 ± 3.12

1.47 ± 3.51
2.68 ± 2.01

0.96 ± 2.43
0.68 ± 3.06

Abs ∆ (mm2)
 Mid
 Post
% ∆b
 Mid
 Post††

17395.9 ± 2555.3
17334.9 ± 2474.7

Values are mean ± SD. TR70, high intensity 70% 1RM; TR45, moderate intensity 45% 1RM; BFR20, blood flow restriction 20%1RM; CON, control; MCSA, mid-thigh muscle crosssectional area; Abs Δ-absolute change vs. Pre; % Δ-percent change vs. Pre. bSignificant training effect.
*p ≤ 0.05 vs. pre. **p ≤ 0.01 vs. pre. †p ≤ 0.05 vs. mid. ††p ≤ 0.01 vs. mid.
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FIGURE 2 | Percent changes in body composition variables pre to post-training. TR70, high intensity 70% 1RM; TR45, moderate intensity 45% 1RM; BFR20,
blood flow restriction 20% 1RM; CON, control; FM, fat mass; BFLBM, Bone-free lean body mass; and FFM, fat-free mass.

in Supplementary Table 4. Effect sizes for three way repeated
measures ANOVA hormone analyses are shown in
Supplementary Table 2. Large effect sizes (np2 ≥ 0.1379) were
observed for the significant effects from the three way repeated
measures ANOVA for all hormones. There were no significant
group differences or week differences in resting testosterone,
and IGF-1 concentrations. Resting IGFBP-3 concentrations were
significantly higher (p = 0.025) in the BFR20 group compared
to TR70, and week 6 resting cortisol was significantly lower
than week 1 (p = 0.001).
There were significant time (p = 0.001, np2 = 0.271) and
training × time interaction (p = 0.019, np2 = 0.140) effects for
testosterone. After decomposing the model, week 1 testosterone
significantly increased from Pre to IP for week 1 (p = 0.0004),
while week 6 testosterone had a significant group × time
interaction (p = 0.03) as only the TR70 group showed a significant
increase (p = 0.005) Pre to IP. Percent change in testosterone
also showed a significant training effect (p = 0.006; Figure 3C)
as significantly larger percent increases in testosterone occurred
in week 1 compared to week 6. Correcting for plasma volume
shifts eliminated the time effect, retained the training × time
effect (p = 0.011), and added a significant group × time effect
(p = 0.019) for testosterone responses. Both TR45 (p = 0.023)
and BFR20 (p = 0.049) had significant decreases in corrected
testosterone concentrations from Pre to IP.
Cortisol had a significant training effect (p < 0.002, np2 = 0.332)
as there was a significant decrease in serum cortisol concentrations
from week 1 to 6. There were no significant group, training,
or group × training interaction effects for percent changes in

TABLE 3 | Plasma volume changes and blood lactate responses from preexercise (Pre) to immediately post-exercise (IP) at week 1 (WK1) and week 6
(WK6) of resistance training.
Group
Variable

PV∆ WK1 (%)
PV∆ WK6 (%)

TR70
(n = 12)
−8.3 ± 1.7
(n = 11)
−7.9 ± 1.8*

Lactate (mmol/L)c
 WK1 Pre
0.88 ± 0.44
 WK1 IP
8.93 ± 2.56**†
 WK6 Pre
0.94 ± 0.88
 WK6 IP
10.05 ± 2.17**††

TR45
(n = 9)
−8.2 ± 1.7
−10.8 ± 2.1**
1.03 ± 0.75
8.23 ± 1.67**
0.81 ± 0.33
7.64 ± 2.56**

BFR20
(n = 12)
−5.2 ± 2.5
(n = 11)
−8.9 ± 2.3*
1.55 ± 1.46
6.33 ± 2.69**
0.91 ± 0.52
5.66 ± 3.01**

CON
(n = 8)
 .8 ± 4.2
0
(n = 6)
1.5 ± 2.5
1.04 ± 0.59
0.88 ± 0.13
0.99 ± 0.60
0.74 ± 0.29

Values are means ± SD. TR70, high intensity 70% 1RM; TR45, moderate intensity 45%
1RM; BFR20, blood flow restriction 20% 1RM; CON, control; PVΔ, plasma volume
change. cSignificant group × time interaction.
*p ≤ 0.05. **p ≤ 0.01 significant vs. CON. †p ≤ 0.05. ††p ≤ 0.01 significant vs. BFR20
group.

for plasma volume changes; however, the significant time effects
(p < 0.0001) remained for CTX-I.

Hormone Responses

Hormone responses to acute resistance exercise for weeks 1
and 6 of training are presented in Table 5, percent changes
in hormone concentrations are shown in Figure 3, and hormone
concentrations corrected for plasma volume shifts are shown
Frontiers in Physiology | www.frontiersin.org
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for IGF-1 percent changes with TR70 showing greater percent
increases (p = 0.002) in IGF-1 vs. CON (Figure 3E). There
were no longer any significant effects for IGF-1 after correcting
for plasma volume shifts.
There were significant group (p = 0.048, np2 = 0.190), time
(p = 0.016, np2 = 0.147) and group × time interaction (p < 0.0001,
np2 = 0.470) effects for IGFBP-3. After decomposing the model,
TR70 had significantly increased (p = 0.001) IGFBP-3 Pre to IP,
TR45 had significantly increased (p = 0.002) IGFBP-3 only in week
6, CON had a significant decrease (p = 0.029) in IGFBP-3 Pre to
IP, and BFR20 did not have any significant changes in IGFBP-3.
There was a significant group effect (p < 0.001) for percent changes
in IGFBP-3 as the training groups had greater percent changes
than CON (all p ≤ 0.001; Figure 3F). Correcting IGFBP-3 IP
concentrations for plasma volume shifts eliminated the group × time
interaction, but retained the significant group (p = 0.007) and time
(p < 0.0001) effects. TR70 had significantly lower IGFBP-3
concentrations than BFR20, and there was a significant decrease
in IGFBP-3 from Pre to IP time points.

TABLE 4 | Bone marker responses (uncorrected for plasma volume shifts) preexercise (Pre), immediately post-exercise (IP), and 60 min post-exercise (60P) at
week 1 (WK1) and week 6 (WK6) of resistance training.
Variable

Group
TR70 (n = 12)

Bone ALP (U/L)cd
 WK1
40.54 ± 13.68
Pre
 WK1 IP 43.04 ± 13.61**
 WK1
38.94 ± 13.41**††
60P
 WK6
41.93 ± 12.13
Pre
 WK6 IP 45.84 ± 12.99**
 WK6
40.74 ± 11.56**††
60P
Abs ∆ (U/L)
 WK1 IP
 WK1
60P
 WK6 IP
 WK6
60P

TR45 (n = 9)

BFR20 (n = 12)

40.52 ± 10.58 36.17 ± 12.18

CON (n = 8)

42.87 ± 15.99

42.00 ± 8.60 37.48 ± 11.00 42.95 ± 15.97
40.65 ± 11.44 35.84 ± 11.49†† 43.92 ± 17.51
38.86 ± 10.97 36.15 ± 12.89

42.87 ± 13.81

42.89 ± 10.52 39.15 ± 11.89 41.66 ± 13.33
38.64 ± 10.08 35.09 ± 10.24†† 43.09 ± 15.74

2.50 ± 1.75
−1.60 ± 3.14

1.48 ± 2.71
0.14 ± 2.51

1.30 ± 1.87
−0.33 ± 3.00

0.07 ± 1.72
1.05 ± 3.72

3.91 ± 2.65
−1.19 ± 1.89

4.02 ± 6.06
−0.22 ± 3.38

2.99 ± 5.72
−1.06 ± 5.63

−1.22 ± 1.25
0.21 ± 4.47

1.29 ± 0.53

1.17 ± 0.45

1.02 ± 0.44

1.00 ± 0.28

1.21 ± 0.46

1.07 ± 0.51

0.96 ± 0.44

0.95 ± 0.26

1.04 ± 0.41

1.03 ± 0.52

0.72 ± 0.31

0.71 ± 0.19

1.13 ± 0.53

1.18 ± 0.46

1.00 ± 0.41

1.03 ± 0.35

1.09 ± 0.43

1.07 ± 0.42

1.03 ± 0.42

0.97 ± 0.35

1.02 ± 0.42

0.85 ± 0.34

0.81 ± 0.36

0.79 ± 0.17

−0.10 ± 0.24
−0.14 ± 0.39

−0.07 ± 0.18
−0.29 ± 0.29

−0.09 ± 0.12
−0.29 ± 0.20

−0.11 ± 0.14
−0.33 ± 0.23

0.03 ± 0.20
−0.19 ± 0.25

−0.05 ± 0.09
−0.23 ± 0.23

CTX-I (ng/ml)
 WK1
Pre
 WK1
IP**
 WK1
60P**††
 WK6
Pre
 WK6
IP**
 WK6
60P**††

Muscle Strength

Lower body strength results are shown in Table 6 and percent
changes in KE and KF strength variables are shown in Figure 4.
There were no differences between the groups at baseline for
any of the strength measures. There were significant training
and group × training interaction effects for both KE and KF
strength variables (all p ≤ 0.001, np2 = 0.261 to 0.576). The models
were decomposed using one-way repeated measures ANOVAs
with Bonferroni post hoc tests. All training groups showed
significant increases from pre to mid for KE (all p ≤ 0.018) and
KF (all p ≤ 0.027), and from pre to post training for KE (p ≤ 0.001)
and KF (all p ≤ 0.017). There were no significant differences
between mid and post for KE, however, KF strength significantly
increased from mid to post for TR70 (p = 0.008) and BFR20
(p = 0.05). CON had no significant changes in KE or KF strength
over the 6 week period. Group comparisons of percent changes
in KE strength showed TR70 had greater strength gains than
CON for mid (p = 0.002) and post (p = 0.002) time points
(Figure 4A). BFR20 had greater percent increases in KF strength
than CON for mid (p = 0.027) and post (p = 0.002) time points,
and TR70 had greater percent increases in KF strength than
CON for the post time point (p = 0.002; Figure 4B). There were
few significant correlations between hormone and strength absolute
change variables. The testosterone absolute change at week 1
was positively correlated with KE absolute change at week 3
(r = 0.32, p = 0.044). Absolute change in IGFBP-3 at week 1 was
positively correlated with KF absolute changes at week 3 (r = 0.51,
p = 0.001) and week 6 (r = 0.37, p = 0.017). Upper body strength
measures are shown in Supplementary Table 5.

d

Abs ∆ (ng/ml)
 WK1 IP −0.07 ± 0.09
 WK1
−0.25 ± 0.21
60P
 WK6 IP −0.05 ± 0.10
 WK6
−0.11 ± 0.17
60P

Values are means ± SD. TR70, high intensity 70% 1RM; TR45, moderate intensity 45%
1RM; BFR20, blood flow restriction 20% 1RM; CON, control; Bone ALP, bone-specific
alkaline phosphatase; CTX-I, C-terminal telopeptide of type I collagen; Abs Δ from Pre.
c
p ≤ 0.001 significant group × time interaction. dp ≤ 0.001 significant time effect.
**p ≤ 0.01 vs. Pre. ††p ≤ 0.001 vs. IP.

cortisol (Figure 3D). Adjusting IP cortisol concentrations for
plasma volume shifts retained the training effect (p < 0.0002)
and added a significant time effect (p = 0.003) with cortisol
decreasing from Pre to IP.
IGF-1 had a significant time effect (p < 0.0001, np2 = 0.192);
overall, IGF-1 significantly increased from Pre to IP. There
also was a trend for a significant group × training interaction
(p = 0.051, np2 = 0.192) as TR70 had significant IGF-1 increases
pre to IP for both week 1 (p = 0.005) and week 6 (p = 0.001),
and both BFR20 (p = 0.002) and TR45 (p = 0.021) had significant
increases in IGF-1 for week 6 only. There were no significant
effects for CON. There was a significant group effect (p = 0.004)
Frontiers in Physiology | www.frontiersin.org
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The unique findings of this study were that high intensity
resistance exercise (TR70) and low intensity blood flow restriction
resistance exercise (BFR20) elicited significant acute bone formation
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FIGURE 3 | Percent changes in bone markers (Panel A Bone ALP, Panel B CTX-I) and hormones (Panel C Testosterone, Panel D Cortisol, Panel E IGF-I, Panel F
IGFBP-3) from pre-exercise (Pre) to immediately post-exercise (IP) for week 1 (WK1) and week 6 (WK6) of training. TR70, high intensity 70% 1RM; TR45, moderate
intensity 45% 1RM; BFR20, blood flow restriction 20% 1RM; CON, control; Bone ALP, bone-specific alkaline phosphatase; CTX-I, C-terminal cross-linking
telopeptide of type I collagen; IGF-1, insulin-like growth factor-1; IGFBP-3, insulin-like growth factor binding protein-3; ap ≤ 0.002 significant vs. CON; dp ≤ 0.001
significant time effect vs. 60P; ep = 0.027 significant training × time interaction.

marker (Bone ALP) responses, but the bone resorption marker
(CTX-I) was not affected by any of the acute exercise protocols.
In addition, the 6 week training programs did not alter acute
Bone ALP marker responses, however, the acute decrease in
CTX-I was attenuated after training in the TR70 group suggesting
a chronic adaptation. Acute and chronic hormone responses to
the resistance exercise protocols differed based on training group.
The TR70 group showed consistent acute increases in testosterone,
IGF-1, and IGFBP-3 for both weeks 1 and 6 of training, and
also had a greater percent increase in testosterone at week 6
compared to week 1. BFR20 had significant acute increases in
testosterone at weeks 1 and 6 and in IGF-1 at week 6. TR45
had significant acute increases in testosterone at week 1 and

Frontiers in Physiology | www.frontiersin.org

in IGF-1 and IGFBP-3 at week 6. All groups had decreases in
serum cortisol concentrations from week 1 to 6.

Bone Marker Responses

Significant changes in bone formation markers in response
to acute bouts of BFR resistance exercise have not been
reported previously. Our findings support our hypothesis
that acute Bone ALP responses would be similar for TR70
and BFR20 groups. In our study, the primary mechanism
for the increased serum Bone ALP concentrations was likely
hemoconcentration as adjusting for plasma volume shifts
eliminated the significant response. Circadian rhythm and
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TABLE 5 | Hormone responses (uncorrected for plasma volume shifts) pre-exercise (Pre) to immediately post-exercise (IP) at week 1 (WK1) and week 6 (WK6) of
resistance training.
Group
Variable
TR70 (n = 12)

TR45 (n = 9)

BFR20 (n = 12)

Testosterone (ng/ml)ce
 WK1 Pre

4.62 ± 1.24
5.21 ± 1.27
4.82 ± 1.74
5.36 ± 1.95**

5.84 ± 2.85
6.34 ± 2.53
5.89 ± 2.08
5.51 ± 2.37

4.57 ± 2.45
4.99 ± 2.44
5.10 ± 2.68
5.13 ± 2.85

4.54 ± 1.42

 WK1 IP**
 WK6 Pre
 WK6 IP
Abs ∆ (ng/m)
 WK1
 WK6

0.59 ± 0.52
0.55 ± 0.54

0.50 ± 0.84
−0.38 ± 1.13

0.41 ± 0.57
0.03 ± 0.51

0.50 ± 1.31
−0.08 ± 0.46

Cortisol (μg/dL)b
 WK1 Pre
 WK1 IP
 WK6 Pre††
 WK6 IP††

CON (n = 8)

5.04 ± 2.48
5.14 ± 2.20
5.06 ± 2.09

30.18 ± 9.99
31.12 ± 7.95
24.45 ± 8.68
25.62 ± 11.77

30.29 ± 14.90
33.37 ± 22.79
28.71 ± 17.4
24.13 ± 11.59

29.40 ± 11.14
28.06 ± 14.46
25.24 ± 8.27
23.64 ± 11.16

23.01 ± 8.63
20.06 ± 11.78
19.01 ± 8.07
19.29 ± 9.15

Abs ∆ (μg/dL)
 WK1
 WK6

0.94 ± 6.25
1.17 ± 5.23

3.08 ± 11.18
−4.59 ± 6.73

−1.34 ± 10.33
−1.60 ± 5.20

−2.94 ± 4.06
0.28 ± 5.80

IGF-1 (ng/ml)d
 WK1 Pre
 WK1 IP
 WK6 Pre
 WK6 IP

137.32 ± 48.73
159.17 ± 55.68**
137.26 ± 59.23
150.55 ± 63.39**

130.88 ± 44.06
136.90 ± 49.69
144.20 ± 44.64
161.39 ± 57.31*

131.76 ± 44.40
139.12 ± 45.00
145.32 ± 49.04
157.48 ± 50.23**

129.50 ± 73.32
139.94 ± 105.19
98.71 ± 33.94
96.90 ± 39.00

Abs ∆ (ng/ml)
 WK1
 WK6

20.81 ± 17.86
13.29 ± 9.14

6.02 ± 14.23
17.19 ± 18.05

7.36 ± 9.48
12.16 ± 10.24

10.44 ± 43.97
−1.81 ± 11.65

2160.98 ± 491.63
2300.38 ± 420.17**
2032.23 ± 306.47
2242.02 ± 502.94**

2442.78 ± 283.63
2497.93 ± 267.97
2353.86 ± 274.93
2598.10 ± 372.74**

2609.21 ± 479.05
2717.69 ± 458.50
2665.36 ± 659.23
2697.48 ± 654.30

2387.45 ± 343.59
2199.03 ± 341.56*
2355.07 ± 692.00
2204.61 ± 530.59*

IGFBP-3 (ng/ml)acd
 WK1 Pre
 WK1 IP
 WK6 Pre
 WK6 IP
Abs ∆ (ng/ml)
 WK1
 WK6

139.40 ± 170.50
209.79 ± 250.07

55.15 ± 78.61
244.24 ± 161.0

108.48 ± 200.96
32.11 ± 233.15

−188.42 ± 252.75
−150.46 ± 223.44

Values are mean ± SD. TR70, high intensity 70% 1RM; TR45, moderate intensity 45% 1RM; BFR20, blood flow restriction 20% 1RM; CON, control; IGF-1, insulin-like growth factor-1;
IGFBP-3, insulin-like growth factor binding protein-3; Abs Δ-absolute change vs. Pre.
a
Significant group effect.
b
Significant training effect.
c
Significant group × time interaction.
d
Significant time effect.
e
Significant training × time interaction.
*p ≤ 0.05. **p ≤ 0.01 vs. Pre. †p ≤ 0.05. ††p ≤ 0.01 vs. WK1.

seasonal variations are sources of variability in serum bone
marker concentrations (Szulc et al., 2019). For example,
CTX-I shows large diurnal variation, peaking after midnight
then decreasing throughout the day, and seasonal changes
in vitamin D alter bone formation and resorption rates
reflected by changes in bone markers (Szulc et al., 2019).
Since we observed a significant decrease in CTX-I Pre to
60P in the control group as well as in all training groups,
the underlying mechanism was likely a circadian rhythm
effect rather than an exercise response. Previously, we reported
the bone resorption marker (NTX-I) significantly decreased
after an acute bout of low load BFR training in young men
and correcting for plasma volume changes strengthened this

Frontiers in Physiology | www.frontiersin.org

response (Bemben et al., 2007). The explanation for the
discrepant findings is not clear since the same BFR device
and exercise protocol were used in both studies. BFR resistance
exercise may affect bone cell activity by stimulating changes
in pH and hypoxia (McCarthy, 2006), thereby activating
factors [e.g., hypoxia induced transcription factor (HIF),
vascular endothelial growth factor (VEGF)] important for
formation of new blood vessels in bone tissue (Araldi and
Schipani, 2010). In support of this mechanism, BFR training
has been shown to increase serum VEGF concentrations
(Takano et al., 2005; Patterson et al., 2013; Zhao et al.,
2020). BFR also may alter vascular endothelial cell secretory
functions (e.g., interleukin-6, endothelin-1, and nitric oxide)
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causing a disruption in the coupling process between bone
resorption and formation. The evidence for this mechanism
is mixed as studies have reported significant increases
(Patterson et al., 2013) and no change in interleukin-6
(Bugera et al., 2018) to single bouts of BFR resistance exercise
as well as increases (Zhao et al., 2020) and no change
(Karabulut et al., 2013) in interleukin-6 to BFR resistance
training programs.
In contrast to previous studies, Bone ALP responses did
not show a training adaptation for any group; however,
TR70 had an attenuated CTX-I decrease at week 6 compared
to week 1. Karabulut et al. (2011) reported similar increases
(~21%–23%) in resting Bone ALP serum concentrations after

6 weeks of BFR resistance training (20% 1RM) and high
intensity (80% 1RM) resistance training in older men.
Although we used the same BFR device and the same
protocol, Karabulut et al. (2011) had their participants
perform leg press instead of knee flexion. In a 12 week
study comparing BFR (30% 1RM) resistance training to
moderate-high intensity (60%–80% 1RM) resistance training
in postmenopausal women, Linero and Choi (2021) found
an increase in CTX-I only in the moderate-high intensity
training group. Although significant increases in the bone
formation maker, P1NP, occurred for both training groups,
the control group also had a significant increase suggesting
this response was not caused by the training programs, but
rather the effect of sources of biological variability (e.g.,
seasonal changes in bone turnover).

TABLE 6 | Lower body 1RM strength (kg) for each group at baseline (pre), week
3 (mid), and post-training (post).

Hormone Responses

Our findings did not support our hypothesis that TR70 and
BFR20 groups would have similar acute hormone responses
to the exercise protocols. Overall, the TR70 protocol was the
most consistent stimulus for eliciting acute increases in
testosterone, IGF-1, and IGFBP-3 both at week 1 and 6 of
training. The BFR20 group had significant acute increases in
testosterone (week 1 and 6) and IGF-1 (week 6), while TR45
had significant increases in testosterone at week 1 and in IGF-1
and IGFBP-3 at week 6. The acute hormone responses, with
the exception of IGF-1, were not attributed to plasma volume
shifts. Cortisol decreased from week 1 to week 6 in all groups,
which also was not explained by plasma volume changes. Our
findings agree with previous studies documenting increases in
testosterone (Madarame et al., 2010; Yinghao et al., 2021) and
IGF-1 (Takano et al., 2005; Madarame et al., 2010; Yinghao
et al., 2021) and no change in cortisol (Patterson et al., 2013)
in response to a single bout of BFR resistance exercise. Few
studies have examined the endocrine adaptations to BFR
resistance training programs. Karabulut et al. (2013) found no
significant changes in resting serum testosterone, IGF-1, or
IGFBP-3 concentrations after 6 weeks of BFR resistance training
in older men.

Group
Variable
TR70 (n = 12)
KE (kg)bc
 Pre
 Mid
 Post
Abs ∆ (kg)
 Mid
 Post
KF (kg)bc
 Pre
 Mid
 Post
Abs ∆ (kg)
 Mid
 Post

99.0 ± 16.9
121.2 ± 24.9**
130.4 ± 32.2**†
22.2 ± 14.7
31.4 ± 17.4
96.7 ± 16.7
107.0 ± 22.2**
120.6 ± 25.4**††
10.3 ± 11.2
23.9 ± 12.7

TR45 (n = 9)

BFR20 (n = 12)

CON (n = 8)

101.6 ± 31.9
88.1 ± 14.8
90.3 ± 17.7
101.0 ± 17.3** 101.8 ± 19.3** 104.9 ± 35.3
106.0 ± 14.9** 109.6 ± 23.0**† 106.8 ± 35.0
12.9 ± 10.5
17.9 ± 11.2
85.6 ± 9.2
93.4 ± 11.0**
97.0 ± 12.5*
7.9 ± 6.3
11.4 ± 11.1

11.5 ± 7.7
19.3 ± 13.2
87.0 ± 20.3
99.0 ± 15.3**
105.3 ± 16.1**†
11.9 ± 9.5
18.3 ± 11.2

3.3 ± 8.5
5.1 ± 10.7
97.0 ± 25.0
95.2 ± 23.5
95.4 ± 26.0
−1.8 ± 11.9
−1.6 ± 10.4

Values are mean ± SD. TR70, high intensity 70% 1RM; TR45, moderate intensity 45%
1RM; BFR20, blood flow restriction 20% 1RM; CON, control; KE, knee extension
strength; KF, knee flexion strength; Abs Δ-absolute change vs. Pre.
b
Significant training effect.
c
Significant group × training interaction.
*p ≤ 0.05 vs. Pre. **p ≤ 0.01 vs. Pre. †p ≤ 0.05 vs. Mid. ††p ≤ 0.01 vs. Mid.

A

B

FIGURE 4 | Percent changes in lower body muscular strength for knee extension (Panel A) and knee flexion (Panel B). TR70, high intensity 70% 1RM; TR45,
moderate intensity 45% 1RM; BFR20, blood flow restriction 20% 1RM; CON, control.
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Endocrine responses to resistance exercise depend on the
training protocol characteristics, such as exercise choice, intensity,
volume, and rest periods; all are important determinants of
increased metabolic demand resulting in changes in physiological
conditions (e.g., increased lactate, hypoxia) that stimulate
hormone secretion (Spiering et al., 2008). Recent muscle
hypertrophy models recognize that protein synthesis is not
regulated solely by hormone responses, but also by mechanical
deformation and immune responses, and that all of these
activate signaling pathways within skeletal muscle leading to
increased translation and transcription, and ultimately, increased
protein synthesis (Kraemer et al., 2020; Gharahdaghi et al.,
2021). Testosterone and IGF-1 exert their anabolic effects
through the mTOR pathway and satellite cell proliferation and
differentiation, and testosterone regulates gene expression through
binding to its androgen receptors on the cell nucleus (Kraemer
et al., 2020; Gharahdaghi et al., 2021). The similar magnitude
of the testosterone responses for the resistance exercise groups
at week 1 suggests all groups were metabolically challenged
enough at the onset of training to elicit increased testosterone
release; however, only TR70 showed a training adaptation for
testosterone. Cortisol, a catabolic hormone responsible for
degrading protein and inhibition of protein synthesis, is typically
upregulated following an acute bout of resistance exercise
(Kraemer et al., 2020). In our study, the decreased resting
cortisol levels, in conjunction with the acute increases in
testosterone may provide a testosterone:cortisol ratio that would
favor increased protein synthesis.

in protein synthesis to breakdown rates improved by 24 h post
BFR resistance exercise since there was minimal change in
protein breakdown rates.
In this randomized control trial, we controlled for sources of
biological error affecting bone marker and hormone responses,
such as dietary intake and time of day for the acute testing
sessions, and we also adjusted bone marker and hormone
concentrations for plasma volume shifts. There are several limitations
to our study. Our bone assessments were limited to bone markers
as the short duration of the training programs did not allow
sufficient time to assess bone mineral density changes by
DXA. Another consideration is that bone marker and hormone
concentrations may have been affected by seasonal changes since
the study was conducted from early to late fall. A disadvantage
of our standardized approach for setting cuff pressures was that
it did not allow for individualized restrictive pressure settings
that are currently recommended in the literature (Freitas et al., 2021).
In conclusion, low intensity BFR resistance training was effective
for stimulating acute bone formation marker responses, although
fewer acute hormone responses were observed for this protocol
compared to high intensity traditional resistance exercise. BFR
and moderate intensity resistance training groups had similar
endocrine responses and muscular adaptations; however, the acute
bone marker responses were different, suggesting that BFR training
may be superior to moderate intensity resistance training for
stimulating bone formation. There were no significant bone marker
adaptations to chronic BFR resistance training, and cortisol decreased
from week 1 to week 6 of BFR resistance training. The gains in
lower body strength and muscle CSA were similar for the training
groups. This study confirmed that low intensity BFR training can
be performed safely in young men. The chronic effects of BFR
resistance training on bone metabolism and bone mineral density
remains to be determined, requiring longer duration interventions.

Muscle Strength and Size

In our study, BFR resistance training elicited similar knee flexion
and extension strength gains as high intensity and moderate
intensity traditional resistance exercise protocols. While the BFR20
group had ~9% lower knee extension strength gain than TR70
group, this difference was not statistically significant. A recent
meta-analysis reported significantly lower strength gains (~7%)
with BFR compared to high intensity resistance exercise (Lixandrão
et al., 2018). As noted by Lixandrão et al. (2018), previous training
studies may not have incorporated progression in the BFR protocols,
whereas we increased cuff pressures every 2 weeks and increased
training loads after week 3. There also is a possibility that strength
gains with BFR protocols may be delayed as Bjørnsen et al. (2019)
reported peak gains in muscle strength occurred 20 days after
the training program.
Although all three training groups increased thigh muscle
CSA, the underlying cellular mechanisms for hypertrophy may
be different. Previous literature has identified activation of the
mTOR pathway as being a potent stimulator of protein synthesis
and subsequent muscle growth (Drummond et al., 2008;
Dickinson et al., 2011), but BFR may follow a different response
pattern than high intensity resistance exercise. Gundermann
et al. (2014) documented a biphasic pattern for increased
protein synthesis rates after an acute BFR resistance exercise
protocol, in contrast to a continuous 24 h elevation in protein
synthesis rates typically observed for high intensity resistance
exercise protocols (Fry et al., 2013). However, the net balance
Frontiers in Physiology | www.frontiersin.org
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